HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Increased susceptibility of mice to Salmonella infection following in vivo treatment with the substance P antagonist, spantide II.

Abstract
Successful resolution of salmonellosis in naive mice depends in large part upon IL-12-induced IFN-gamma production to eliminate this intracellular pathogen of macrophages. In the present study we questioned the contribution that expression of substance P receptors makes to the protective response following oral inoculation with a lethal dose of Salmonella. Such a relationship was suggested when oral inoculation with Salmonella induced rapid and dramatic increases in substance P receptor mRNA expression within Peyer's patches and mesenteric lymph nodes and subsequently in the spleen. The importance of substance P receptor expression in vivo was further suggested by pretreatment of mice with the substance P antagonist, spantide II, before oral inoculation with Salmonella. Mice pretreated with spantide II and then orally inoculated developed advanced salmonellosis and had significantly reduced survival rates compared with mice pretreated with a control peptide. Treatment with spantide II significantly reduced early Salmonella-induced IL-12p4O and IFN-gamma mRNA expression at mucosal sites, suggesting a mechanism for the reduced ability of spantide II-treated mice to resist this pathogen. Increased susceptibility to salmonellosis was not due to 1) spantide II-induced alterations in the uptake of this pathogen from the gut, 2) global spantide II-mediated immune suppression, or 3) nonsubstance P receptor-mediated effects of spantide II on macrophages. The ability of Salmonella to induce substance P receptor expression on cultured macrophages suggested that one mechanism for resistance against this intracellular pathogen might be a direct effect of substance P on this cell population.
AuthorsT Kincy-Cain, K L Bost
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 157 Issue 1 Pg. 255-64 (Jul 01 1996) ISSN: 0022-1767 [Print] United States
PMID8683123 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • RNA, Messenger
  • Receptors, Neurokinin-1
  • spantide II
  • Interleukin-12
  • Substance P
  • Interferon-gamma
Topics
  • Administration, Oral
  • Amino Acid Sequence
  • Animals
  • Base Sequence
  • Cells, Cultured
  • Disease Susceptibility
  • Female
  • Interferon-gamma (biosynthesis)
  • Interleukin-12 (biosynthesis)
  • Leukocytes, Mononuclear (drug effects, immunology)
  • Lymphocyte Activation (drug effects)
  • Macrophage Activation (drug effects)
  • Mice
  • Mice, Inbred BALB C
  • Molecular Sequence Data
  • RNA, Messenger (biosynthesis)
  • Receptors, Neurokinin-1 (biosynthesis, genetics)
  • Salmonella Infections, Animal (etiology, immunology, mortality)
  • Substance P (administration & dosage, analogs & derivatives, antagonists & inhibitors, biosynthesis, genetics, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: